Vaxa
Profile
Vaxa has developed a disruptive new technology platform perfecting the cultivation of Omega-3 rich micro-algae. Bringing a new scientific approach, our technology, as compared to the current state of the art, requires less than 1% of the fresh water, less than 1% of the land footprint and is carbon negative. We are constantly improving the growth and performance of each strain using machine learning and data analytics techniques.
Competences & Capabilities
- First indoor controlled omega-3 & production from micro algae
- Consistent composition, pathogen-free, bio-secured
- Less than 1% of freshwater and land
- Negative CO2 footprint
- Strong IP and know-how
- 5 times omega-3 composition,10 times yield
- 1/5 production cost
- Enables a unique offering for large addressable markets
- Aquaculture – hatchery, polishing feed
- Human supplements, colourants, protein
- Experienced management & scientific team
more
Related
news
In October 2022, EIT Food North-West hosted small food businesses and industry experts in Iceland to encourage collaboration and new overseas partnerships.
project
Increasing the sustainability of European aquaculture
CovidX
2020
project
The CovidX project investigated whether a food supplement based on a novel Spirulina-extract has the ability to strengthen the immune system and help reduce infection risk of SARS-CoV-2 infection.
project
Creative infotaining is the future of knowledge transfer and co-creation among young generations.
Energy-to-Feed (E2F)
2020
project
E2F will develop a sustainable source of protein & lipid from omega-3 rich microalgae cultivated using clean power sources (Geothermal/Hydro) & natural CO₂.
ThermoBlue
2020 > 2022
project
Developing a natural blue food colouring